Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney

References

Page 1

	Year	Citations
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus New England Journal of Medicine	1993	24.5K
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel, New England Journal of Medicine	2008	7.6K
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia Assam El‐Osta, Daniella Brasacchio, Dachun Yao, The Journal of Experimental Medicine	2008	1.1K
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1) Georg F. Weber, Samy Ashkar, Melvin J. Glimcher, Science SclerostinBone Morphogenic ProteinMedicineCell AdhesionImmunology	1996	941
Physical Association and Coordinate Function of the H3 K4 Methyltransferase MLL1 and the H4 K16 Acetyltransferase MOF Yali Dou, Thomas A. Milne, Alan J. Tackett, Cell Physical AssociationCellular EnzymologyBiochemistryNatural SciencesBiochemical Genetics	2005	665
Osteopontin Expression in Cardiovascular Diseases<sup>a</sup> Cecilia M. Giachelli, Lucy Liaw, Charles E. Murry, Annals of the New York Academy of Sciences SclerostinCell AdhesionImmunologyAdhesive InteractionsCytoskeleton	1995	183
A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1 Hanna Huopio, Timo Otonkoski, Ilkka Vauhkonen, The Lancet Genetic DeterminantAutosomal Dominant DiabetesGenetic DisorderGeneticsDiabetes	2003	182
Beyond Hemoglobin A<sub>1c</sub>—Need for Additional Markers of Risk for Diabetic Microvascular Complications Irl B. Hirsch JAMA Intensive TherapyBeyond Hemoglobin AAdditional MarkersType 1Diabetic Retinopathy	2010	180
Molecular Profiling of Diabetic Mouse Kidney Reveals Novel Genes Linked to Glomerular Disease Katalin Suszták, Erwin P. Böttinger, Akiva P. Novetsky, Diabetes	2004	149
Contribution of human uropontin to inhibition of calcium oxalate crystallization John R. Asplin, Denise Arsenault, Joan H. Parks, Kidney International UrologyBiochemistryBiomineralizationPhysiologyCytoskeleton	1998	126

Page 1